Community-Centered Patient Journey Map in Opioid Use Disorder: A Tool to Address Compassion Fatigue among Community Pharmacists

Author:

Hohmeier Kenneth Charles1ORCID,Cernasev Alina1,Leibold Christina1,Moore Todd M.2,Schlesinger Erica3,Cochran Gerald4,Arce Ileana3,Geminn Wesley3,Chisholm-Burns Marie5

Affiliation:

1. Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Nashville, TN 37211, USA

2. Department of Psychology, University of Tennessee, Knoxville, TN 37996, USA

3. Tennessee Department of Mental Health & Substance Abuse Services, Nashville, TN 37243, USA

4. Division of Epidemiology, University of Utah, Salt Lake City, UT 84112, USA

5. Office of the Provost, Oregon Health & Science University, Portland, OR 97239, USA

Abstract

Community pharmacists have become increasingly exposed to opioid use disorders in recent decades. However, both pharmacist training and traditional practice environments have not been adequate to prepare the pharmacist for both the patient care needs and regulatory barriers of patients experiencing opioid use disorders (OUD). As a result, there is a need to increase pharmacists’ awareness of both the overall patient experience as they navigate their OUD and the role of the community pharmacy as a touchpoint within that experience. To this end, a Community-Centered Patient Journey in Drug Addiction Treatment journey map was developed with expert insights, clinical experience, and in-depth interviews (conducted in spring of 2021) with 16 participants enrolled in licensed opioid treatment programs in Tennessee. Patients, policymakers, clinicians, and academic researchers were involved in the map development. Lived experiences of key informants were captured via in-depth interviews. A consensus decision-making approach was used throughout the patient journey map development process. The final patient journey map illustrates a non-linear pathway, describes the central role of the patient’s community, and emphasizes three major “pain points” within the system (access, adherence, and affordability). Future research should investigate the impact of such a journey map on pharmacy personnel’s knowledge, attitudes, and behaviors.

Funder

University of Tennessee System

Publisher

MDPI AG

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Reference40 articles.

1. Buprenorphine maintenance versus placebo or methadonemaintenance for opioid dependence;Mattick;Cochrane Database Syst. Rev.,2014

2. Medication-assisted therapies–tackling the opioid-overdoseepidemic;Volkow;N. Engl. J. Med.,2014

3. Opioid agonist treatment and fatal overdose risk in a state-wide USpopulation receiving opioid use disorder services;Krawczyk;Addiction,2020

4. The Centers for Disease Control and Prevention (2022, October 07). National Center for Health Statistics, Available online: https://www.cdc.gov/nchs/.

5. Opioid epidemic in the United States;Manchikanti;Pain Physician,2012

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3